135 related articles for article (PubMed ID: 14769842)
21. Comparative image analysis of conventional and thin-layer preparations in endometrial cytology.
Hattori M; Kobayashi TK; Nishimura Y; Machida D; Toyonaga M; Tsunoda S; Ohbu M
Diagn Cytopathol; 2013 Jun; 41(6):527-32. PubMed ID: 22807421
[TBL] [Abstract][Full Text] [Related]
22. Morphometrical Differences among Endometrial Endometrioid Carcinoma Grade 1, Grade 3, and Serous Carcinoma in Endometrial Liquid-Based Cytology Preparations.
Odashima H; Yoshioka H; Minami K; Miyakawa K; Horie K; Norimatsu Y; Yanoh K; Watanabe J
Acta Cytol; 2022; 66(6):524-531. PubMed ID: 36096095
[TBL] [Abstract][Full Text] [Related]
23. Endometrial carcinosarcomas have a different prognosis and pattern of spread compared to high-risk epithelial endometrial cancer.
Amant F; Cadron I; Fuso L; Berteloot P; de Jonge E; Jacomen G; Van Robaeys J; Neven P; Moerman P; Vergote I
Gynecol Oncol; 2005 Aug; 98(2):274-80. PubMed ID: 15972232
[TBL] [Abstract][Full Text] [Related]
24. Gene expression profiles in stage I uterine serous carcinoma in comparison to grade 3 and grade 1 stage I endometrioid adenocarcinoma.
Mhawech-Fauceglia P; Wang D; Kesterson J; Syriac S; Clark K; Frederick PJ; Lele S; Liu S
PLoS One; 2011 Mar; 6(3):e18066. PubMed ID: 21448288
[TBL] [Abstract][Full Text] [Related]
25. Endometrial carcinomas: a review emphasizing overlapping and distinctive morphological and immunohistochemical features.
Bartosch C; Manuel Lopes J; Oliva E
Adv Anat Pathol; 2011 Nov; 18(6):415-37. PubMed ID: 21993268
[TBL] [Abstract][Full Text] [Related]
26. Pap smears in women with endometrial carcinoma.
Gu M; Shi W; Barakat RR; Thaler HT; Saigo PE
Acta Cytol; 2001; 45(4):555-60. PubMed ID: 11480718
[TBL] [Abstract][Full Text] [Related]
27. [The significance of endometrial cells in the cervical smear].
Doornewaard H; Sie-Go DM; Woudt JM; Kooijman CD
Ned Tijdschr Geneeskd; 1993 Apr; 137(17):868-72. PubMed ID: 8487901
[TBL] [Abstract][Full Text] [Related]
28. Characterization of the endometrial, cervicovaginal and anorectal microbiota in post-menopausal women with endometrioid and serous endometrial cancers.
Gressel GM; Usyk M; Frimer M; Kuo DYS; Burk RD
PLoS One; 2021; 16(11):e0259188. PubMed ID: 34739493
[TBL] [Abstract][Full Text] [Related]
29. [Clinical characteristics of 42 cases of malignant endometrial polyps].
Tang Z; Zhou R; Bao D; Liu C; Wei L
Zhonghua Fu Chan Ke Za Zhi; 2014 Mar; 49(3):204-7. PubMed ID: 24820306
[TBL] [Abstract][Full Text] [Related]
30. Expression of p53 in imprint smears of endometrial carcinoma.
Kosmas K; Stamoulas M; Marouga A; Kavantzas N; Patsouris E; Athanassiadou P
Diagn Cytopathol; 2014 May; 42(5):416-22. PubMed ID: 24167025
[TBL] [Abstract][Full Text] [Related]
31. Immunohistochemical characterization of prototypical endometrial clear cell carcinoma--diagnostic utility of HNF-1β and oestrogen receptor.
Hoang LN; Han G; McConechy M; Lau S; Chow C; Gilks CB; Huntsman DG; Köbel M; Lee CH
Histopathology; 2014 Mar; 64(4):585-96. PubMed ID: 24103020
[TBL] [Abstract][Full Text] [Related]
32. IMP3 distinguishes uterine serous carcinoma from endometrial endometrioid adenocarcinoma.
Mhawech-Fauceglia P; Herrmann FR; Rai H; Tchabo N; Lele S; Izevbaye I; Odunsi K; Cheney RT
Am J Clin Pathol; 2010 Jun; 133(6):899-908. PubMed ID: 20472848
[TBL] [Abstract][Full Text] [Related]
33. Abnormal cervical cytology in the diagnosis of uterine papillary serous carcinoma: earlier detection of a poor prognostic cancer subtype?
Skaznik-Wikiel ME; Ueda SM; Frasure HE; Rose PG; Fleury A; Grumbine FC; Fader AN
Acta Cytol; 2011; 55(3):255-60. PubMed ID: 21525737
[TBL] [Abstract][Full Text] [Related]
34. Undifferentiated Carcinoma of the Endometrium: An Expanded Immunohistochemical Analysis Including PAX-8 and Basal-Like Carcinoma Surrogate Markers.
Ramalingam P; Masand RP; Euscher ED; Malpica A
Int J Gynecol Pathol; 2016 Sep; 35(5):410-8. PubMed ID: 26598976
[TBL] [Abstract][Full Text] [Related]
35. Coordinate expression of Cdc25B and ER-alpha is frequent in low-grade endometrioid endometrial carcinoma but uncommon in high-grade endometrioid and nonendometrioid carcinomas.
Wu W; Slomovitz BM; Celestino J; Chung L; Thornton A; Lu KH
Cancer Res; 2003 Oct; 63(19):6195-9. PubMed ID: 14559803
[TBL] [Abstract][Full Text] [Related]
36. Human kallikrein 6: a new potential serum biomarker for uterine serous papillary cancer.
Santin AD; Diamandis EP; Bellone S; Soosaipillai A; Cane S; Palmieri M; Burnett A; Roman JJ; Pecorelli S
Clin Cancer Res; 2005 May; 11(9):3320-5. PubMed ID: 15867230
[TBL] [Abstract][Full Text] [Related]
37. Clinicopathologic review of malignant polyps in stage 1A carcinoma of the endometrium.
Farrell R; Scurry J; Otton G; Hacker NF
Gynecol Oncol; 2005 Aug; 98(2):254-62. PubMed ID: 15936803
[TBL] [Abstract][Full Text] [Related]
38. Utility of the cervical cytologic smear in assessing endocervical involvement by endometrial carcinoma.
Zuna RE; Erroll M
Acta Cytol; 1996; 40(5):878-84. PubMed ID: 8842160
[TBL] [Abstract][Full Text] [Related]
39. Markers of proliferative activity are predictors of patient outcome for low-grade endometrioid adenocarcinoma but not papillary serous carcinoma of endometrium.
Al Kushi A; Lim P; Aquino-Parsons C; Gilks CB
Mod Pathol; 2002 Apr; 15(4):365-71. PubMed ID: 11950909
[TBL] [Abstract][Full Text] [Related]
40. [Application of immunohistochemistry in differential diagnosis of endometrial carcinoma].
Wu HW; Liu TH
Zhonghua Bing Li Xue Za Zhi; 2012 Nov; 41(11):784-8. PubMed ID: 23302346
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
